Tech Company Inital Public Offerings

Twist Bioscience IPO

On 10/30/2018, Twist Bioscience went public.

Transaction Overview

Company Name
Announced On
10/30/2018
Transaction Type
IPO
Amount
$70,000,000
Proceeds Purpose
Approximately $15 million to $20 million to improve and update our platform and core technologies by investing in equipment, expanding our research and development capabilities and establishing new (and scalable) operation facilities; approximately $15 million to $18 million to expand our sales and marketing capabilities in the U.S., Europe and Asia, including approximately $2 million to $3 million to establish our sales and marketing capabilities in China; approximately $12 million to $14 million to continue to expand in the pharmaceutical biologics drug discovery and DNA data storage markets; approximately $5 million to $10 million to establish our operations in China; and any proceeds not applied to the foregoing will be used for working capital and general corporate purposes.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
455 Mission Bay Blvd South
San Francisco, CA 94158
USA
Phone
Undisclosed
Email Address
Overview
At Twist Bioscience (Nasdaq: TWST), our expertise is accelerating science and innovation by leveraging the power of scale. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, including genes, oligonucleotide pools and variant libraries.
Profile
Twist Bioscience LinkedIn Company Profile
Social Media
Twist Bioscience Company Twitter Account
Company News
Twist Bioscience News
Facebook
Twist Bioscience on Facebook
YouTube
Twist Bioscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Emily Leproust
  Emily Leproust LinkedIn Profile  Emily Leproust Twitter Account  Emily Leproust News  Emily Leproust on Facebook
Chief Financial Officer
Solange Glaize
  Solange Glaize LinkedIn Profile  Solange Glaize Twitter Account  Solange Glaize News  Solange Glaize on Facebook
Chief Operating Officer
Bill Banyai
  Bill Banyai LinkedIn Profile  Bill Banyai Twitter Account  Bill Banyai News  Bill Banyai on Facebook
Chief Technical Officer
Bill Peck
  Bill Peck LinkedIn Profile  Bill Peck Twitter Account  Bill Peck News  Bill Peck on Facebook
VP - Operations
Patrick Weiss
  Patrick Weiss LinkedIn Profile  Patrick Weiss Twitter Account  Patrick Weiss News  Patrick Weiss on Facebook
VP - Sales
Patrick Finn
  Patrick Finn LinkedIn Profile  Patrick Finn Twitter Account  Patrick Finn News  Patrick Finn on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/29/2018: Phytelligence venture capital transaction
Next: 10/30/2018: Properly Rental venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary